Buscar resultados de ensayos clínicos
Myelofibrosis - 57 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis Condición: Myelofibrosis Fecha: 2013-03-14 Intervenciones:
|
Completed |
Nombre del estudio: Pilot Trial of Arsenic + Cytarabine in Patients With Myelofibrosis Condición: Myelofibrosis Fecha: 2007-12-11 Intervenciones:
|
Recruiting |
Nombre del estudio: A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis Condición: Myelofibrosis Fecha: 2017-02-27 Intervenciones:
|
Completed |
Nombre del estudio: Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients Condición: Myelofibrosis Fecha: 2008-01-11 Intervenciones: Procedure: Allogeneic Stem Cell Transplantation Allogeneic Stem Cell Transplantation after dose-reduced |
Recruiting |
Nombre del estudio: Trial Ruxolitinib and Peg-interferon Alpha-2a Combination in Patients With Primary Myelofibrosis RUXOPeg Condición: Myelofibrosis Fecha: 2016-03-08 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Pegylated Interferon Alpha-2b in Early Primary Myelofibrosis Condición: Myelofibrosis Fecha: 2012-12-24 Intervenciones: Drug: Peginterferon alfa-2a 50 mcg subcutaneous injection once per week |
Suspended |
Nombre del estudio: Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor Condición: Primary Myelofibrosis Fecha: 2015-04-21 Intervenciones:
|
Terminated |
Nombre del estudio: A Phase II Study of Re-treatment of Myelofibrosis Patients With Ruxolitinib/Jakavi After Treatment Interruption Due to Loss of Response and/or Adverse Event (ReTreatment Trial) Condición: Primary Myelofibrosis Fecha: 2014-03-06 Intervenciones: Drug: Ruxolitinib Starting dose was based on reason for previous discontinuation of ruxolitinib (i.e. lo |
Completed |
Nombre del estudio: Thalidomide in Treating Patients With Myelofibrosis Condición: Primary Myelofibrosis Fecha: 2001-05-06 Intervenciones:
|
Withdrawn |
Nombre del estudio: A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in Myelofibrosis Condición: Primary Myelofibrosis Fecha: 2015-10-21 Intervenciones: Biological: Pacritinib QD (Once a day) |